Literature DB >> 22161156

Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

A Mansour1, M Nabil, R Ali-Labib, H Said, F Annos.   

Abstract

There is an intimate relation between disturbance in survivin and SMAC/DIABLO expressions and cancer formation in many tissues; however, this was not confirmed in the primary breast cancer. The aim of this study was to evaluate the relationship between survivin and SMAC/DIABLO mRNA expressions in primary breast cancer using RT-PCR and their relationship to some of the risk factors (age, family history, breast-feeding, use of contraceptive pills and hormonal receptors). Breast cancer tissues were studied for the detection of the mRNA expression of survivin and SMAC/DIABLO. This was done by qualitative reverse transcription-polymerase chain reaction (RT-PCR). SMAC/DIABLO mRNA was detected by RT-PCR only in 1 sample in breast cancer tissues (6.25%). However, it was expressed in 16 out of 25 (64%) of the benign tumor tissues (P=0.00). In contrast, survivin mRNA was highly expressed in breast cancer tissues, 36 out of 48 (75%) (P=0.00), while its expression was very low in benign tumor tissues, only 1 out of 37 (2.7%) (P=0.00). Expressions of SMAC/DIABLO and survivin were significantly reciprocal in breast cancer and benign tumor tissues. SMAC/DIABLO inhibits apoptosis of breast cancer cells by suppression of survivin. These two genes probably form an important link in the signaling pathway of formation of breast cancer cells, which may be chosen as therapeutic targets in the primary breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22161156     DOI: 10.1007/s12032-011-0129-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  48 in total

1.  Oral contraceptives and the risk of breast cancer.

Authors:  Polly A Marchbanks; Jill A McDonald; Hoyt G Wilson; Suzanne G Folger; Michele G Mandel; Janet R Daling; Leslie Bernstein; Kathleen E Malone; Giske Ursin; Brian L Strom; Sandra A Norman; Phyllis A Wingo; Ronald T Burkman; Jesse A Berlin; Michael S Simon; Robert Spirtas; Linda K Weiss
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

2.  A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors.

Authors:  C S Duckett; V E Nava; R W Gedrich; R J Clem; J L Van Dongen; M C Gilfillan; H Shiels; J M Hardwick; C B Thompson
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Anti-apoptosis gene, survivin, and prognosis of neuroblastoma.

Authors:  C Adida; D Berrebi; M Peuchmaur; M Reyes-Mugica; D C Altieri
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

4.  Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.

Authors:  Jennifer A Rusiecki; Theodore R Holford; Shelia H Zahm; Tongzhang Zheng
Journal:  Cancer Detect Prev       Date:  2005-09-23

5.  Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.

Authors:  Nikki L Neubauer; Erin C Ward; Parin Patel; Zhenxiao Lu; Irene Lee; Leen J Blok; Payman Hanifi-Moghaddam; Julian Schink; J Julie Kim
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

6.  Apoptotic and antiapoptotic mechanisms after traumatic brain injury.

Authors:  R W Keane; S Kraydieh; G Lotocki; O F Alonso; P Aldana; W D Dietrich
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

7.  JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells.

Authors:  Dharminder Chauhan; Guilan Li; Teru Hideshima; Klaus Podar; Constantine Mitsiades; Nicholas Mitsiades; Nikhil Munshi; Surender Kharbanda; Kenneth C Anderson
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

8.  Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.

Authors:  Zhiyin Song; Xuebiao Yao; Mian Wu
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

9.  A single BIR domain of XIAP sufficient for inhibiting caspases.

Authors:  R Takahashi; Q Deveraux; I Tamm; K Welsh; N Assa-Munt; G S Salvesen; J C Reed
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

Review 10.  Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women.

Authors:  T G Ijaduola; E B Smith
Journal:  J Natl Med Assoc       Date:  1998-09       Impact factor: 1.798

View more
  5 in total

1.  Dysregulated Expression of Apoptosis-Associated Genes and MicroRNAs and Their Involvement in Gastric Carcinogenesis.

Authors:  Mayara Luciana Sallas; Diana Zapparoli; Mônica Pezenatto Dos Santos; Jéssica Nunes Pereira; Wilson Aparecido Orcini; Rita Luiza Peruquetti; Elizabeth Suchi Chen; Marilia de Arruda Cardoso Smith; Spencer Luiz Marques Payão; Lucas Trevizani Rasmussen
Journal:  J Gastrointest Cancer       Date:  2021-06

Review 2.  ILP-2: A New Bane and Therapeutic Target for Human Cancers.

Authors:  Zhiliang Zhang; Siqi Xiang; Ruxia Cui; Hang Peng; Roy Mridul; Mingjun Xiang
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin.

Authors:  Elizabeth Tarasewicz; Randala Hamdan; Joelle Straehla; Ashley Hardy; Omar Nunez; Stanislav Zelivianski; Danijela Dokic; Jacqueline S Jeruss
Journal:  Cancer Biol Ther       Date:  2014-07-09       Impact factor: 4.742

Review 4.  Specificity Protein 1: A Protein With a Two-Sided Role in Ischemic Stroke.

Authors:  Qinyang Yu; Wangyang Liu; Zhuohui Chen; Mengqi Zhang
Journal:  Front Cell Neurosci       Date:  2021-12-14       Impact factor: 5.505

5.  Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms.

Authors:  Jacques A J Malherbe; Kathryn A Fuller; Bob Mirzai; Simon Kavanagh; Chi-Chiu So; Ho-Wan Ip; Belinda B Guo; Cecily Forsyth; Rebecca Howman; Wendy N Erber
Journal:  J Clin Pathol       Date:  2016-04-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.